(Q43242638)

17 November 2017

title

Atrial fibrillation and anticoagulation in a stroke unit population (English)

1 reference

17 November 2017

1 reference

1 reference

6

1 reference

17 November 2017

O Ahmad

1

1 reference

17 November 2017

K E Ahmad

2

1 reference

17 November 2017

K B G Dear

3

1 reference

17 November 2017

I Harvey

4

1 reference

17 November 2017

A Hughes

5

1 reference

17 November 2017

publication date

1 November 2009

1 reference

Internal Medicine Journal

17 November 2017

published in

1 reference

17 November 2017

volume

39

1 reference

17 November 2017

issue

11

1 reference

17 November 2017

page(s)

752-756

1 reference

Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

17 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01878.X

Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01878.X

Classification and natural history of clinically identifiable subtypes of cerebral infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01878.X

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01878.X

10.1111/J.1445-5994.2008.01878.X

21 January 2018

Identifiers

DOI

1 reference

17 November 2017

1 reference